Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma
- 27 April 2021
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 43 (9) , 2602-2610
Abstract
Background: To evaluate the value of locoregional radiation therapy (LRRT) in de novo metastatic nasopharyngeal carcinoma (mNPC) and identify suitable candidates for additional LRRT after palliative chemotherapy (PCT).Methods: Patients with de novo mNPC received platinum‐based chemotherapy for a minimum of four cycles with or without definitive LRRT via intensity‐modulated radiation therapy (IMRT) were all candidates for this study.Results: A total of 168 patients were included for this analysis. Additional LRRT was associated with significantly longer median OS (69.5 vs. 17.8 months, p < 0.001) when compared with PCT alone. However, this survival benefit of LRRT was only reflected in patients with oligometastatic diseases (90.8 vs. 17 months, p < 0.001), but not for those with polymetastatic disease (p = 0.86).Conclusions: Additional LRRT after PCT may only improve OS for oligometastatic patients. For patients with polymetastatic disease, intensive systemic treatment such as the combination of immunotherapy and adequate PCT might be necessary.Keywords
Funding Information
- National Natural Science Foundation of China (81972717)
This publication has 25 references indexed in Scilit:
- Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort StudyFrontiers in Oncology, 2020
- Synchronous Metastatic Nasopharyngeal Carcinoma: Characteristics and Survival of Patients Adding Definitive Nasopharyngeal-Neck Radiotherapy to Systematic ChemotherapyCancer Management and Research, 2020
- Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal CarcinomaJAMA Oncology, 2020
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2020
- Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal CancerJournal of the National Comprehensive Cancer Network, 2017
- Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapyRadiotherapy and Oncology, 2017
- Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2012
- Update on the Management and Therapeutic Monitoring of Advanced Nasopharyngeal CancerHematology/Oncology Clinics of North America, 2008
- Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directionsCancer Science, 2008